A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306579 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Arif Jamal Siddiqui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Machine Learning, Molecular Docking Simulation, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Salman Center for Disability Research.
Abstract (Originalsprache)
The G protein-coupled receptor 40 (GPR40) is known to exert a significant influence on neurogenesis and neurodevelopment within the central nervous system of both humans and rodents. Research findings indicate that the activation of GPR40 by an agonist has been observed to promote the proliferation and viability of hypothalamus cells in the human body. The objective of the present study is to discover new agonist compounds for the GPR40 protein through the utilization of machine learning and pharmacophore-based screening techniques, in conjunction with other computational methodologies such as docking, molecular dynamics simulations, free energy calculations, and investigations of the free energy landscape. In the course of our investigation, we successfully identified five unreported agonist compounds that exhibit robust docking score, displayed stability in ligand RMSD and consistent hydrogen bonding with the receptor in the MD trajectories. Free energy calculations were observed to be higher than control molecule. The measured binding affinities of compounds namely 1, 3, 4, 6 and 10 were -13.9, -13.5, -13.4, -12.9, and -12.1 Kcal/mol, respectively. The identified molecular agonist that has been found can be assessed in terms of its therapeutic efficacy in the treatment of neurological diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
- Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah, Saudi Arabia.
- Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
- Department of Biosciences, Faculty of Science, Integral University, Lucknow, India.
ORCID-Profile: Arif Jamal Siddiqui, Riadh Badraoui, Mohd Adnan
Förderung
- King Salman Center for Disability Research
Zitieren
APA
Siddiqui, A. J., Badraoui, R., Alshahrani, M. M., Snoussi, M., Jahan, S., Siddiqui, M. A., Khan, A., Sulieman, A. M. E., & Adnan, M. (2024). A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment. PLOS ONE. https://doi.org/10.1371/journal.pone.0306579
Vancouver
Siddiqui AJ, Badraoui R, Alshahrani MM, Snoussi M, Jahan S, Siddiqui MA, et al. A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment. PLOS ONE. 2024. doi:10.1371/journal.pone.0306579
BibTeX
@article{Siddiqui2024,
author = {Siddiqui, Arif Jamal and Badraoui, Riadh and Alshahrani, Mohammed Merae and Snoussi, Mejdi and Jahan, Sadaf and Siddiqui, Maqsood Ahmed and Khan, Andleeb and Sulieman, Abdel Moneim E and Adnan, Mohd},
title = {A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306579}
}
EUVIMED